Maria Gerogianni

Maria Gerogianni is a Clinical Network Project Manager at Cure51 since April 2024, focusing on developing a global clinical and multiomics database of exceptional cancer survivors. Prior to this role, Maria worked as a Digital Medicine VC at Sofinnova Partners, invested in transformative healthcare technologies, and as a Venture Analyst at Start Codon, conducting due diligence on early-stage life sciences companies. Maria was also the Head of VC at CUVCPE, leading initiatives to support students in venture capital. Additional experience includes roles at InHealth Ventures, Revena, Illumina, P.Happi, and the Biomedical Research Foundation of the Academy of Athens, where Maria contributed to research and consultancy in various areas of life sciences. Maria holds a Master of Philosophy in Bioscience Enterprise from the University of Cambridge and has a background in international education.